IQVIA Holdings | IQV - 销售成本





销售成本 更改 日
Accenture USD 12.58B 896K 2026-03
Agilent USD 845M 7M 2026-03
Bruker USD 422.5M 21.1M 2026-06
Cardinal Health USD 61.23B 2.7B 2026-06
Celltrion KRW 92.83B 14.59B 2026-03
Charles River Laboratories USD 655.29M 61.22M 2026-06
Cigna USD 65.13B 2.72B 2026-06
Cognizant Technology Solutions USD 3.8B 16M 2026-06
Cspc Pharmaceutical CNY 2.11B 173.58M 2025-12
CVS Health USD 90.35B 5.54B 2026-06
Danaher USD 2.65B 294M 2026-06
Dentsply International USD 405M 48M 2026-06
Deva Holding AS TRY 991.13M 182.81M 2023-09
Divis Laboratories Ltd INR 11.19B 1.2B 2026-06
Elevance Health USD 38.07B 75M 2025-12
Humana USD 26.54B 1.15B 2025-03
IBM USD 7.29B 325M 2026-06
Illumina USD 389M 19M 2026-06
Infosys INR 98.48B 98.44B 2026-06
Kangmei Pharma CNY 841.45M 271.27M 2026-03
Knight Therapeutics CAD 82.22M 1.03M 2025-12
Laboratorios Farma EUR 186.09M 11.06M 2023-12
Laboratory Of America USD 2.7B 97.8M 2026-06
McKesson USD 101.7B 9.44B 2026-06
Mettler Toledo International USD 396.52M 14.4M 2026-06
Organigram Holdings CAD 43.39M 13.54M 2026-03
Pharma Mar EUR 4.73M 1.08M 2026-06
Qiagen NV USD 196.45M 13.73M 2026-06
Quest Diagnostics USD 2.05B 64M 2026-06
Revvity USD 312.82M 10.64M 2026-06
Sartorius EUR 478.7M 5.9M 2026-06
Sino Biopharmaceutical CNY 3.08B 589.65M 2025-06
Thermo Fisher Scientific USD 7.54B 577M 2026-06
Tilray USD 164.37M 8.41M 2025-09
UnitedHealth USD 86.31B 8.41B 2026-03
Veeva Systems USD 220.92M 7.45M 2026-03
Veradigm USD 124.74M 56.25M 2022-12
Waters USD 1.16B 430M 2026-06
Zealand Pharma A/S 410K 5K 2025-06
Zz Pientze Pharmaceu CNY 1.58B 245.15M 2026-03